PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-117.41%
Both yoy net incomes decline, with BTE at -89.91%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-3.65%
Negative yoy D&A while BTE is 176.70%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-300.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-34.78%
Negative yoy SBC while BTE is 37.55%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-2135.29%
Both reduce yoy usage, with BTE at -373.79%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-1001.95%
AR is negative yoy while BTE is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
141.16%
AP growth of 141.16% while BTE is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-2135.29%
Both reduce yoy usage, with BTE at -373.79%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
33766.67%
Well above BTE's 100.78%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-7.43%
Both yoy CFO lines are negative, with BTE at -17.29%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-7.13%
Both yoy lines negative, with BTE at -103.57%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1293.71%
Both yoy lines negative, with BTE at -100.59%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Growth well above BTE's 271.37%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-2.96%
Both yoy lines negative, with BTE at -24.69%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-6900.00%
Both yoy lines negative, with BTE at -10946.80%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
35.69%
Buyback growth of 35.69% while BTE is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.